Isotopia Overview
- Founded
- 2006
- Status
- Private
- Employees
- 12
- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $3.06M
- Investors
- 3
Isotopia General Information
Description
Developer of nuclear isotopes intended to provide radioactive isotopes to the growing sector of nuclear medicine in Israel. The company's nuclear isotopes are used for diagnosis and therapy planning in the fields of molecular imaging and radiotherapy, enabling clients related to the molecular imaging and radiotherapy field to get products for molecular imaging that will help them to do a precise diagnosis and improve their therapy planning.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
- 39 Alexander Yanai Street
- Segula Industrial Park
- Petah Tikva 49277
- Israel
+972 00-000-0000
Isotopia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 29-Jul-2007 | $3.06M | 00.000 | Completed | Generating Revenue |
Isotopia Executive Team (7)
Isotopia Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIsotopia Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Ranjo Investments | Other | Minority | 000 0000 | 000000 0 | |
| The Metrontario Group | Real Estate | Minority | 000 0000 | 000000 0 | |
| Tivona Capital | PE/Buyout | Minority | 000 0000 | 000000 0 |